Publicaciones en las que colabora con Francisco Javier Rodríguez-Escudero Sánchez (26)

1997

  1. Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma

    Anticancer Research, Vol. 17, Núm. 3 C, pp. 2147-2151

1996

  1. Abdominal mass in a young woman. Pitfalls and delayed diagnosis. Case report

    European Journal of Gynaecological Oncology, Vol. 17, Núm. 6, pp. 507-509

  2. Chemotherapy-induced emesis: Management of early and delayed emesis in milder emetogenic regimens

    Cancer Chemotherapy and Pharmacology, Vol. 38, Núm. 5, pp. 471-475

  3. Induccion de la ovulacion y cancer ginecologico: Asociaciones clinicas o riesgo real?

    Toko-Ginecologia Practica, Vol. 55, Núm. 610, pp. 246-256

  4. S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers

    Breast Cancer Research and Treatment, Vol. 38, Núm. 3, pp. 265-275

  5. nm23 expression in advanced and borderline ovarian carcinoma

    Anticancer Research, Vol. 16, Núm. 3 A, pp. 1197-1202

1995

  1. Angiosarcoma of the breast and pregnancy: a new therapeutic approach

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 60, Núm. 1, pp. 87-89

1994

  1. Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: Comparison with the results of immunohistochemistry

    European Journal of Cancer, Vol. 30, Núm. 4, pp. 504-508

  2. Intrinsic overexpression of two different mechanisms of resistance to chemotherapy (P-Glycoprotein and GST-π) in human endometrial carcinoma

    Chemotherapy, Vol. 40, Núm. 4, pp. 265-271

  3. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors

    Journal of the National Cancer Institute, Vol. 86, Núm. 11, pp. 850-855

1993

  1. ESTUDIO DE LA SENSIBILIDAD IN VITRO A DIFERENTES ANTIFUNGICOS EN LEVADURAS PROCEDENTES DE AISLAMIENTOS VAGINALES

    Progresos en Obstetricia y Ginecologia, Vol. 36, Núm. 2, pp. 76-81

  2. Elevated serum CA-125 levels in patients with ovarian fibrothecomas

    European Journal of Cancer

  3. High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue

    European Journal of Cancer, Vol. 29, Núm. 4, pp. 554-558

  4. Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety

    European Journal of Gynaecological Oncology, Vol. 14, Núm. 1, pp. 36-39

1992

  1. Giant organised retzius space haematoma simulating a pelvic mass

    Journal of Obstetrics and Gynaecology, Vol. 12, Núm. 5, pp. 341-342

  2. Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue

    American Journal of Obstetrics and Gynecology, Vol. 166, Núm. 3, pp. 825-829

  3. The role of second look laparotomy and tumor markers in the follow-up of endodermal sinus tumor of the ovary. A case report and review of the literature

    European Journal of Gynaecological Oncology, Vol. 13, Núm. 3, pp. 217-222

  4. Variations in estrogen and progesterone receptor levels after short-term tamoxifen treatment in breast carcinoma

    Oncology (Switzerland), Vol. 49, Núm. 6, pp. 422-425

1991

  1. ANALYSE DER TUMORREZIDIVE NACH NEGATIVER SECOND-LOOK-LAPAROTOMIE BEIM OVARIALKARZINOM

    Zentralblatt fur Gynakologie, Vol. 113, Núm. 22, pp. 1246-1250

  2. DUDOSA UTILIDAD DE LA LAPAROTOMIA DE SECOND-LOOK EN EL ESTADIO I DEL CARCINOMA EPITELIAL DE OVARIO

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 18, Núm. 7, pp. 260-262